In season 2, episode 9 of Targeted Talks, Sandy Srinivas, MD and Nicholas J. Vogelzang, MD, discuss he optimal sequencing of therapies for a specific patient with metastatic castration-resistant prostate cancer.

S2 Ep9: Sequencing Therapy for Metastatic Castration-Resistant Prostate Cancer

<div>Targeted Oncology brings you <em>Treating Together</em>, a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.</div>

Science

Health & Fitness

Targeted Oncology brings you Treating Together, a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.

Targeted Oncology brings you <em>Treating Together</em>, a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.

Share S2 Ep9: Sequencing Therapy for Metastatic Castration-Resistant Prostate Cancer

Sign up to save your podcasts

S2 Ep9: Sequencing Therapy for Metastatic Castration-Resistant Prostate Cancer

S2 Ep9: Sequencing Therapy for Metastatic Castration-Resistant Prostate Cancer

More shows like Treating Together

Planet Money

Interesting Times with Ross Douthat